Key result
Angiopoietins are microvascular modulators that interact with VEGF to regulate endothelial permeability, suggesting potential therapeutic applications in glomerular disease and repair.
Design
Review
Authors
Loading...
May guide targeted permeability therapies in glomerular disease; leaves open clinical validation before practice change.
This review highlights the potential of angiopoietins as therapeutic targets for modulating microvascular permeability in glomerular diseases.
Satchell et al. (2003) conducted a review in Glomerular pathophysiology. Angiopoietins was evaluated. Angiopoietins are microvascular modulators that interact with VEGF to regulate endothelial permeability, suggesting potential therapeutic applications in glomerular disease and repair.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: